Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-16

Clinical Trial Update: The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating miltefosine in combination with pentoxifylline for mucosal and cutaneous leishmaniasis in Brazil.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Miltefosine (miltefosine)
  • Pentoxifylline (pentoxifylline)

Snippet

Sponsor: University of Brasilia | Conditions: Leishmaniasis | Phase 2 | Status: ACTIVE_NOT_RECRUITING